These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2696353)

  • 1. Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
    Remuzzi G
    Adv Exp Med Biol; 1989; 259():221-47. PubMed ID: 2696353
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolism and action mechanisms of eicosanoids and platelet-activating factor in the kidney].
    Watanabe T
    Nihon Rinsho; 1992 Dec; 50(12):2937-48. PubMed ID: 1337118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration.
    Schambelan M; Don BR; Kaysen GA; Blake S
    Adv Exp Med Biol; 1989; 259():275-304. PubMed ID: 2696356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Eicosanoids and glomerular disease].
    Kuroda M
    Nihon Rinsho; 1990 Jun; 48(6):1270-5. PubMed ID: 2384974
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal diseases and platelet activating factor].
    Pirotzky E; Colliez P; Guilmard C; Braquet P
    Pediatrie; 1989; 44(3):163-7. PubMed ID: 2740184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of reactive oxygen species in the development of glomerular injury.
    Kakuta S; Nakamura K; Shimomura M; Suzuki Y; Oda K; Hidaka S; Nagase M
    Contrib Nephrol; 1993; 101():255-62. PubMed ID: 8467683
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview of eicosanoid metabolism and relationship to platelet-activating factor.
    Dusting GJ; Stewart AG
    Reprod Fertil Dev; 1990; 2(5):417-21. PubMed ID: 2075239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis.
    Bustos C; González-Cuadrado S; Ruiz-Ortega M; Gómez-Guerrero C; González E; Plaza JJ; Egido J
    Clin Exp Immunol; 1995 Dec; 102(3):608-13. PubMed ID: 8536380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.
    Diamond JR; Pesek I; Ruggieri S; Karnovsky MJ
    Am J Physiol; 1989 Nov; 257(5 Pt 2):F798-807. PubMed ID: 2589483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in the sialoglycoprotein content of the glomerular basement membrane in experimental nephrosis.
    Quatacker J
    Acta Histochem Suppl; 1987; 34():107-8. PubMed ID: 3107051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uninephrectomy aggravates tubulointerstitial injury in rats with adriamycin nephrosis.
    Chagnac A; Korzets A; Ben-Bassat M; Zevin D; Hirsh J; Meckler J; Levi J
    Nephron; 1994; 66(2):176-80. PubMed ID: 8139738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulointerstitial injury and impaired renal function after recovery from acute puromycin nephrosis.
    Baboolal K; Meyer TW
    Am J Physiol; 1995 Sep; 269(3 Pt 2):F331-8. PubMed ID: 7573481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of glomerular barrier function in early adriamycin nephrosis of MWF rats.
    Soose M; Haberstroh U; Rovira-Halbach G; Brunkhorst R; Stolte H
    Clin Physiol Biochem; 1988; 6(6):310-5. PubMed ID: 3208483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of eicosanoids and PAF in immune-complex alveolitis.
    Tavares-de-Lima W; Teixeira CF; Sirois P; Jancar S
    Braz J Med Biol Res; 1989; 22(6):745-8. PubMed ID: 2620187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal dysfunction in animal models of cyclosporine toxicity.
    Paller MS; Murray BM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):155-9. PubMed ID: 3895656
    [No Abstract]   [Full Text] [Related]  

  • 19. Micropuncture study of albumin transfer in aminonucleoside nephrosis in the rat.
    Lewy JE; Pesce A
    Pediatr Res; 1973 Jun; 7(6):553-9. PubMed ID: 4708973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electron microscopic study on the glomerular vascular permeability in various experimental nephropathies].
    Aihara K
    Nihon Ika Daigaku Zasshi; 1967; 34(4):219-27. PubMed ID: 5582511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.